ARCHIVES

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Roswell Park Wins $2.8 Million Grant

July 31, 2009

Reaction: Voices Of Believers Drown Out Skeptics

November 20, 2009

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

Triple-Negative Breast Cancer Equally Aggressive in Whites

February 25, 2011

In Brief: Hohn Named President, CEO Of Roswell Park; Mendelsohn Honored; AACE Elects Officers

February 7, 1997

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012